Cabenuva
- Generic Name: cabotegravir; rilpivirine extended-release injectable suspension
- Brand Name: Cabenuva
- Drug Class: HIV, NNRTIs, HIV, Integrase Inhibitors
Cabenuva (Cabotegravir; Rilpivirine Extended-release Injectable Suspension) side effects drug center
-
Related Drugs
Aptivus Atripla Biktarvy Cimduo Combivir Complera Delstrigo Descovy Dovato Edurant Emtriva Epivir Epzicom Evotaz Fuzeon Genvoya Intelence Invirase Isentress Juluca Kaletra Capsules Kaletra Tablets Lexiva Norvir Norvir Capsules Odefsey Pifeltro Prezcobix Prezista Retrovir Retrovir IV Reyataz Rukobia Selzentry Stribild Sustiva Symfi Symfi Lo Symtuza Tivicay Triumeq Trizivir Trogarzo Truvada Tybost Viramune Viramune XR Viread Vocabria Ziagen
Cabenuva Side Effects Center
What Is Cabenuva?
Cabenuva (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension) is a 2-drug co-packaged product of a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor (INSTI) and an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI), indicated as a complete regimen for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
What Are Side Effects of Cabenuva?
Side effects of Cabenuva include:
- fever,
- fatigue,
- headache,
- musculoskeletal pain,
- nausea,
- Site search
- Contact
- Location map
- For professionals
